Ankush Jamthikar1, Deep Gupta1, Narendra N Khanna2, Tadashi Araki3, Luca Saba4, Andrew Nicolaides5, Aditya Sharma6, Tomaz Omerzu7, Harman S Suri8, Ajay Gupta9, Sophie Mavrogeni10, Monika Turk7, John R Laird11, Athanasios Protogerou12, Petros P Sfikakis13, George D Kitas14, Vijay Viswanathan15, Gyan Pareek16, Martin Miner17, Jasjit S Suri18. 1. Department of ECE, Visvesvaraya National Institute of Technology, Nagpur, Maharashtra, India. 2. Department of Cardiology, Indraprastha APOLLO Hospitals, New Delhi, India. 3. Division of Cardiovascular Medicine, Toho University, Tokyo, Japan. 4. Department of Radiology, University of Cagliari, Cagliari, Italy. 5. Vascular Screening and Diagnostic Centre, University of Cyprus, Nicosia, Cyprus. 6. Cardiovascular Medicine, University of Virginia, Charlottesville, VA, USA. 7. Department of Neurology, University Medical Centre Maribor, Maribor, Slovenia. 8. Brown University, Providence, RI, USA. 9. Department of Radiology, Cornell Medical Center, New York, NY, USA. 10. Cardiology Clinic, Onassis Cardiac Surgery Center, Athens, Greece. 11. Heart and Vascular Institute, Adventist Health St. Helena, St. Helena, CA, USA. 12. Department of Cardiovascular Prevention & Research Unit Clinic & Laboratory of Pathophysiology|, National and Kapodistrian University of Athens, Athens, Greece. 13. Rheumatology Unit, National Kapodistrian University of Athens, Athens, Greece. 14. R&D Academic Affairs, Dudley Group NHS Foundation Trust, Dudley, UK. 15. MV Hospital for Diabetes and Professor M Viswanathan Diabetes Research Centre, Chennai, India. 16. Minimally Invasive Urology Institute, Brown University, Providence, RI, USA. 17. Men's Health Center, Miriam Hospital Providence, Providence, RI, USA. 18. Stroke Monitoring and Diagnostic Division, AtheroPoint™, Roseville, CA, 95661, USA. jasjit.suri@atheropoint.com.
Abstract
PURPOSE OF REVIEW: Cardiovascular disease (CVD) and stroke risk assessment have been largely based on the success of traditional statistically derived risk calculators such as Pooled Cohort Risk Score or Framingham Risk Score. However, over the last decade, automated computational paradigms such as machine learning (ML) and deep learning (DL) techniques have penetrated into a variety of medical domains including CVD/stroke risk assessment. This review is mainly focused on the changing trends in CVD/stroke risk assessment and its stratification from statistical-based models to ML-based paradigms using non-invasive carotid ultrasonography. RECENT FINDINGS: In this review, ML-based strategies are categorized into two types: non-image (or conventional ML-based) and image-based (or integrated ML-based). The success of conventional (non-image-based) ML-based algorithms lies in the different data-driven patterns or features which are used to train the ML systems. Typically these features are the patients' demographics, serum biomarkers, and multiple clinical parameters. The integrated (image-based) ML-based algorithms integrate the features derived from the ultrasound scans of the arterial walls (such as morphological measurements) with conventional risk factors in ML frameworks. Even though the review covers ML-based system designs for carotid and coronary ultrasonography, the main focus of the review is on CVD/stroke risk scores based on carotid ultrasound. There are two key conclusions from this review: (i) fusion of image-based features with conventional cardiovascular risk factors can lead to more accurate CVD/stroke risk stratification; (ii) the ability to handle multiple sources of information in big data framework using artificial intelligence-based paradigms (such as ML and DL) is likely to be the future in preventive CVD/stroke risk assessment.
PURPOSE OF REVIEW: Cardiovascular disease (CVD) and stroke risk assessment have been largely based on the success of traditional statistically derived risk calculators such as Pooled Cohort Risk Score or Framingham Risk Score. However, over the last decade, automated computational paradigms such as machine learning (ML) and deep learning (DL) techniques have penetrated into a variety of medical domains including CVD/stroke risk assessment. This review is mainly focused on the changing trends in CVD/stroke risk assessment and its stratification from statistical-based models to ML-based paradigms using non-invasive carotid ultrasonography. RECENT FINDINGS: In this review, ML-based strategies are categorized into two types: non-image (or conventional ML-based) and image-based (or integrated ML-based). The success of conventional (non-image-based) ML-based algorithms lies in the different data-driven patterns or features which are used to train the ML systems. Typically these features are the patients' demographics, serum biomarkers, and multiple clinical parameters. The integrated (image-based) ML-based algorithms integrate the features derived from the ultrasound scans of the arterial walls (such as morphological measurements) with conventional risk factors in ML frameworks. Even though the review covers ML-based system designs for carotid and coronary ultrasonography, the main focus of the review is on CVD/stroke risk scores based on carotid ultrasound. There are two key conclusions from this review: (i) fusion of image-based features with conventional cardiovascular risk factors can lead to more accurate CVD/stroke risk stratification; (ii) the ability to handle multiple sources of information in big data framework using artificial intelligence-based paradigms (such as ML and DL) is likely to be the future in preventive CVD/stroke risk assessment.
Authors: G Belcaro; A N Nicolaides; G Ramaswami; M R Cesarone; M De Sanctis; L Incandela; P Ferrari; G Geroulakos; A Barsotti; M Griffin; S Dhanjil; M Sabetai; M Bucci; G Martines Journal: Atherosclerosis Date: 2001-06 Impact factor: 5.162
Authors: J David Spence; Michael Eliasziw; Maria DiCicco; Daniel G Hackam; Ramzy Galil; Tara Lohmann Journal: Stroke Date: 2002-12 Impact factor: 7.914
Authors: Viti Kothari; Richard J Stevens; Amanda I Adler; Irene M Stratton; Susan E Manley; H Andrew Neil; Rudy R Holman Journal: Stroke Date: 2002-07 Impact factor: 7.914
Authors: R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham Journal: Eur Heart J Date: 2003-06 Impact factor: 29.983
Authors: Irene M van der Meer; Antonio Iglesias del Sol; A Elisabeth Hak; Michiel L Bots; Albert Hofman; Jacqueline C M Witteman Journal: Stroke Date: 2003-08-28 Impact factor: 7.914
Authors: D H O'Leary; J F Polak; R A Kronmal; S J Kittner; M G Bond; S K Wolfson; W Bommer; T R Price; J M Gardin; P J Savage Journal: Stroke Date: 1992-12 Impact factor: 7.914
Authors: Richard J Stevens; Ruth L Coleman; Amanda I Adler; Irene M Stratton; David R Matthews; Rury R Holman Journal: Diabetes Care Date: 2004-01 Impact factor: 19.112
Authors: Yrjö Leskinen; Terho Lehtimäki; Antti Loimaala; Visa Lautamatti; Timo Kallio; Heini Huhtala; Juha P Salenius; Heikki Saha Journal: Atherosclerosis Date: 2003-12 Impact factor: 5.162
Authors: Ankush D Jamthikar; Deep Gupta; Laura E Mantella; Luca Saba; John R Laird; Amer M Johri; Jasjit S Suri Journal: Int J Cardiovasc Imaging Date: 2020-11-12 Impact factor: 2.357
Authors: Ankush Jamthikar; Deep Gupta; Luca Saba; Narendra N Khanna; Tadashi Araki; Klaudija Viskovic; Sophie Mavrogeni; John R Laird; Gyan Pareek; Martin Miner; Petros P Sfikakis; Athanasios Protogerou; Vijay Viswanathan; Aditya Sharma; Andrew Nicolaides; George D Kitas; Jasjit S Suri Journal: Cardiovasc Diagn Ther Date: 2020-08
Authors: Ankush Jamthikar; Deep Gupta; Elisa Cuadrado-Godia; Anudeep Puvvula; Narendra N Khanna; Luca Saba; Klaudija Viskovic; Sophie Mavrogeni; Monika Turk; John R Laird; Gyan Pareek; Martin Miner; Petros P Sfikakis; Athanasios Protogerou; George D Kitas; Chithra Shankar; Andrew Nicolaides; Vijay Viswanathan; Aditya Sharma; Jasjit S Suri Journal: Cardiovasc Diagn Ther Date: 2020-08
Authors: George Konstantonis; Krishna V Singh; Petros P Sfikakis; Ankush D Jamthikar; George D Kitas; Suneet K Gupta; Luca Saba; Kleio Verrou; Narendra N Khanna; Zoltan Ruzsa; Aditya M Sharma; John R Laird; Amer M Johri; Manudeep Kalra; Athanasios Protogerou; Jasjit S Suri Journal: Rheumatol Int Date: 2022-01-11 Impact factor: 2.631
Authors: Vasiliki Bikia; Terence Fong; Rachel E Climie; Rosa-Maria Bruno; Bernhard Hametner; Christopher Mayer; Dimitrios Terentes-Printzios; Peter H Charlton Journal: Eur Heart J Digit Health Date: 2021-10-18
Authors: Ankush Jamthikar; Deep Gupta; Narendra N Khanna; Luca Saba; Tadashi Araki; Klaudija Viskovic; Harman S Suri; Ajay Gupta; Sophie Mavrogeni; Monika Turk; John R Laird; Gyan Pareek; Martin Miner; Petros P Sfikakis; Athanasios Protogerou; George D Kitas; Vijay Viswanathan; Andrew Nicolaides; Deepak L Bhatt; Jasjit S Suri Journal: Cardiovasc Diagn Ther Date: 2019-10
Authors: Jasjit S Suri; Anudeep Puvvula; Mainak Biswas; Misha Majhail; Luca Saba; Gavino Faa; Inder M Singh; Ronald Oberleitner; Monika Turk; Paramjit S Chadha; Amer M Johri; J Miguel Sanches; Narendra N Khanna; Klaudija Viskovic; Sophie Mavrogeni; John R Laird; Gyan Pareek; Martin Miner; David W Sobel; Antonella Balestrieri; Petros P Sfikakis; George Tsoulfas; Athanasios Protogerou; Durga Prasanna Misra; Vikas Agarwal; George D Kitas; Puneet Ahluwalia; Raghu Kolluri; Jagjit Teji; Mustafa Al Maini; Ann Agbakoba; Surinder K Dhanjil; Meyypan Sockalingam; Ajit Saxena; Andrew Nicolaides; Aditya Sharma; Vijay Rathore; Janet N A Ajuluchukwu; Mostafa Fatemi; Azra Alizad; Vijay Viswanathan; Pudukode R Krishnan; Subbaram Naidu Journal: Comput Biol Med Date: 2020-08-14 Impact factor: 4.589